1. Home
  2. VIVS vs SPRC Comparison

VIVS vs SPRC Comparison

Compare VIVS & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

N/A

Current Price

$0.28

Market Cap

3.8M

Sector

Health Care

ML Signal

N/A

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

N/A

Current Price

$4.80

Market Cap

3.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VIVS
SPRC
Founded
2007
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.3M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
VIVS
SPRC
Price
$0.28
$4.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
619.2K
31.1K
Earning Date
06-04-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,603,000.00
N/A
Revenue This Year
$42.38
N/A
Revenue Next Year
$15.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.82
N/A
52 Week Low
$0.26
$0.46
52 Week High
$4.98
$15.79

Technical Indicators

Market Signals
Indicator
VIVS
SPRC
Relative Strength Index (RSI) 33.99 32.94
Support Level $0.27 $3.95
Resistance Level $0.58 $7.40
Average True Range (ATR) 0.02 0.40
MACD 0.01 -0.14
Stochastic Oscillator 16.83 0.00

Price Performance

Historical Comparison
VIVS
SPRC

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: